Ikarian Capital’s Assembly Biosciences ASMB Stock Holding History

Ikarian Capital’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-18,923	Closed	-$468K	–	145
2022 Q1	$468K	Buy	18,923 +1,018	+6%	+$21.9K	0.06%	139
2021 Q4	$501K	Hold	17,905	–	–	0.07%	128
2021 Q3	$747K	Buy	17,905 +11,866	+196%	+$497K	0.05%	169
2021 Q2	$281K	Hold	6,039	–	–	0.02%	202
2021 Q1	$334K	Hold	6,039	–	–	0.01%	264
2020 Q4	$439K	Sell	6,039 -7,083	-54%	-$831K	0.02%	195
2020 Q3	$2.59M	Hold	13,122	–	–	0.19%	99
2020 Q2	$3.67M	Hold	13,122	–	–	0.29%	78
2020 Q1	$2.33M	Hold	13,122	–	–	0.18%	89
2019 Q4	$3.22M	Buy	+13,122	New	+$2.42M	0.52%	48

Other funds holding ASMB

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital's ASMB Position: Q2 2022 in Review

Ikarian Capital sold out of Assembly Biosciences (ASMB) in Q2 2022, closing a stake of 18,923 shares — an estimated $468K sold.

Ikarian Capital first reported a position in ASMB in Q4 2019 and held it in 10 quarters. The position peaked at $3.67M in Q2 2020. 54 funds tracked by Wall St. Rank hold ASMB as of Q2 2022.

Ikarian Capital reported no remaining Assembly Biosciences position as of Q2 2022 after selling out during the quarter.
Ikarian Capital sold 18,923 Assembly Biosciences shares in Q2 2022, an estimated $468K.
Ikarian Capital first reported a position in Assembly Biosciences in Q4 2019 and held it in 10 quarters.
Ikarian Capital's Assembly Biosciences position peaked at $3.67M in Q2 2020.
54 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2022.

Based on Ikarian Capital's 13F filing for Q2 2022, filed 12 Aug 2022.